(VIANEWS) – Assured Guaranty Ltd. (AGO), Halozyme Therapeutics (HALO), Eagle Point Credit Company (ECC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Assured Guaranty Ltd. (AGO)
142.7% sales growth and 13.25% return on equity
Assured Guaranty Ltd., through its subsidiaries, provides credit protection products to public finance, infrastructure, and structured finance markets in the United States and internationally. The company operates in two segments, Insurance and Asset Management. It offers financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments. The company insures and reinsures various debt obligations, including bonds issued by the United States state, governmental authorities, or municipal governmental authorities; and notes issued to finance infrastructure projects. It also insures and reinsures various types of the U.S. public finance obligations, such as general obligation, tax-backed, municipal utility, transportation, healthcare, higher education, infrastructure, housing revenue, investor-owned utility, renewable energy, and other public finance bonds; non-U.S. public finance obligations comprising regulated utilities, infrastructure finance, sovereign and sub-sovereign, renewable energy bonds, pooled infrastructure, and other public finance obligations; and the U.S. and non-U.S. Structured finance obligations, including residential mortgage-backed securities, insurance securitization obligations, consumer receivables securities, pooled corporate obligations, financial products, and other structured finance securities. In addition, the company provides asset management services comprising investment advisory services, including management of collateralized loan obligations and opportunity funds to outside investors. It markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities, as well as to investors in such obligations. Assured Guaranty Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Assured Guaranty Ltd. has a trailing twelve months EPS of $12.21.
PE Ratio
Assured Guaranty Ltd. has a trailing twelve months price to earnings ratio of 6.4. Meaning, the purchaser of the share is investing $6.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.25%.
Yearly Top and Bottom Value
Assured Guaranty Ltd.’s stock is valued at $78.09 at 20:22 EST, way below its 52-week high of $96.60 and way above its 52-week low of $57.91.
Revenue Growth
Year-on-year quarterly revenue growth declined by 41.4%, now sitting on 865M for the twelve trailing months.
Sales Growth
Assured Guaranty Ltd.’s sales growth is 112% for the ongoing quarter and 142.7% for the next.
2. Halozyme Therapeutics (HALO)
33.5% sales growth and 153.16% return on equity
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.58.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 21.7. Meaning, the purchaser of the share is investing $21.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 153.16%.
Yearly Top and Bottom Value
Halozyme Therapeutics’s stock is valued at $55.99 at 20:22 EST, under its 52-week high of $57.09 and way higher than its 52-week low of $32.83.
3. Eagle Point Credit Company (ECC)
28.5% sales growth and 16.45% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.71.
PE Ratio
Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 5.85. Meaning, the purchaser of the share is investing $5.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.45%.
4. AG Mortgage Investment Trust (MITT)
22.6% sales growth and 11.67% return on equity
AG Mortgage Investment Trust, Inc. operates as a residential mortgage real estate investment trust in the United States. Its investment portfolio comprises residential investments, including non-agency loans, agency-eligible loans, re-and non-performing loans, and non-agency residential mortgage-backed securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2011 and is based in New York, New York.
Earnings Per Share
As for profitability, AG Mortgage Investment Trust has a trailing twelve months EPS of $1.66.
PE Ratio
AG Mortgage Investment Trust has a trailing twelve months price to earnings ratio of 4.41. Meaning, the purchaser of the share is investing $4.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.67%.
Moving Average
AG Mortgage Investment Trust’s value is above its 50-day moving average of $7.02 and way higher than its 200-day moving average of $6.32.
Yearly Top and Bottom Value
AG Mortgage Investment Trust’s stock is valued at $7.32 at 20:22 EST, below its 52-week high of $7.86 and way above its 52-week low of $4.82.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 28, 2024, the estimated forward annual dividend rate is 0.47 and the estimated forward annual dividend yield is 6.42%.
5. Western Alliance Bancorporation (WAL)
20.3% sales growth and 12.24% return on equity
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates through Commercial and Consumer Related segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; demand deposits; and treasury management and residential mortgage products and services. It also offers commercial and industrial loan products, such as working capital lines of credit, loans to technology companies, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans, which are secured by multi-family residential properties, professional offices, industrial facilities, retail centers, hotels, and other commercial properties; construction and land development loans for single family and multi-family residential projects, industrial/warehouse properties, office buildings, retail centers, medical office facilities, and residential lot developments; and consumer loans. In addition, the company provides other financial services, such as internet banking, wire transfers, electronic bill payment and presentment, funds transfer and other digital payment offerings, lock box services, courier, and cash management services. Further, it holds certain investment securities, municipal and non-profit loans, and leases; invests primarily in low-income housing tax credits and small business investment corporations; and holds certain real estate loans and related securities. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Western Alliance Bancorporation has a trailing twelve months EPS of $6.64.
PE Ratio
Western Alliance Bancorporation has a trailing twelve months price to earnings ratio of 12.14. Meaning, the purchaser of the share is investing $12.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.24%.
Previous days news about Western Alliance Bancorporation(WAL)
- According to Zacks on Tuesday, 27 August, "Investors can keep a close watch on stocks like UMB Financial Corporation (UMBF Quick QuoteUMBF – Free Report) , Glacier Bancorp, Inc. (GBCI Quick QuoteGBCI – Free Report) , Pinnacle Financial Partners, Inc. (PNFP Quick QuotePNFP – Free Report) , Western Alliance Bancorporation (WAL Quick QuoteWAL – Free Report) and Regions Financial Corporation (RF Quick QuoteRF – Free Report) , as they are expected to maintain their momentum and keep scaling new highs."
6. Cognex Corporation (CGNX)
13.6% sales growth and 5.25% return on equity
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Earnings Per Share
As for profitability, Cognex Corporation has a trailing twelve months EPS of $0.45.
PE Ratio
Cognex Corporation has a trailing twelve months price to earnings ratio of 85.56. Meaning, the purchaser of the share is investing $85.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.25%.
Volume
Today’s last reported volume for Cognex Corporation is 872555 which is 28.33% below its average volume of 1217580.
Yearly Top and Bottom Value
Cognex Corporation’s stock is valued at $38.50 at 20:22 EST, way below its 52-week high of $53.13 and way above its 52-week low of $34.28.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 18.8% and 54.5%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 15, 2024, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 0.77%.
7. The Ensign Group (ENSG)
12.4% sales growth and 14.78% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $3.89.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 36.49. Meaning, the purchaser of the share is investing $36.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.78%.
Moving Average
The Ensign Group’s value is higher than its 50-day moving average of $129.71 and way higher than its 200-day moving average of $118.97.
Yearly Top and Bottom Value
The Ensign Group’s stock is valued at $141.93 at 20:22 EST, below its 52-week high of $147.93 and way above its 52-week low of $90.00.
8. Gentex Corporation (GNTX)
8.2% sales growth and 18.1% return on equity
Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, and internationally. It operates through Automotive Products and Other segments. The company offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and non-automatic-dimming rearview mirrors for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers. It also provides variable dimmable windows to aircraft manufacturers and airline operators. In addition, the company offers photoelectric smoke detectors and alarms, electrochemical carbon monoxide alarms and detectors, audible and visual signaling alarms, and bells and speakers used in fire detection systems in office buildings, hotels, and other commercial and residential buildings, as well as researches and develops nanofiber chemical sensing products. The company sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. Gentex Corporation was incorporated in 1974 and is headquartered in Zeeland, Michigan.
Earnings Per Share
As for profitability, Gentex Corporation has a trailing twelve months EPS of $1.8.
PE Ratio
Gentex Corporation has a trailing twelve months price to earnings ratio of 16.07. Meaning, the purchaser of the share is investing $16.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.1%.
